Search results
Analysts Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $80.00
ETF DAILY NEWS· 6 hours agoShares of AstraZeneca PLC (NASDAQ:AZN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the ...
AstraZeneca confirms strong vaccine protection after US rift
AOL· 4 hours agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay
Proactive Investors· 2 hours agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with ...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 19 hours agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Given the large stake in the stock by institutions,AstraZeneca's stock price might be...
Angle PLC Announces New Commercial Agreement with AstraZeneca
Digital Journal· 2 hours agoANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY ...
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
InvestorPlace· 13 hours agoThis seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma...
Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics By Benzinga
Investing.com· 1 day agoIn its upcoming report, Astrazeneca (NYSE: AZN) is predicted by Wall Street analysts to post...
Greenleaf Trust Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 3 days agoGreenleaf Trust trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with ...
Zacks Research Weighs in on AstraZeneca PLC’s Q2 2025 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for shares of AstraZeneca in a ...